Endocrine Disorders Flashcards

1
Q

ADA screening recommendations for dm

A

annual if bmi >25 and one/more risk factors for dm
every 3 yrs otherwise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

prediabetes values

A

hga1c- 5.7-6.4%
FPG- 100-125
OGTT- 140-199

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

types ii dm values

A

hga1c- >6.5%
fpg- >126
ogtt- >200
random glucose with symptoms- >200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hga1c suggested goals

A

most adults- <7%
healthy older adults- <7.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

physical exam monitoring for dm type ii

A

foot exam every 3 months
eye exam annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

recommendations for frequency of a1c testing in type ii dm

A

every 3 months if not at goal
otherwise every 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

biguanide example

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

sulfonylurea 2nd examples

A

glimepiride
glipzide
glyburide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

meglitinides med example

A

repglinide
nateglinide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

dpp-4 inhibit med examples

A

alogliptin
linagliptin
saxagliptin
sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

glp-1 med examples

A

exenatide
liraglutide
dulaglutide
semaglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

tzd med examples

A

pioglitazone
rosiglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

sglt2 med examples

A

canaglifozin
dapaglifozin
empaglifozin
ertuglifolozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

sulfonylurea MOA and SE

A

potentiates insulin secretion
hypoglycemia, weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dpp-4 moa and se

A

slows inactivation of incretin
“gliptins”, don’t use initially

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

glp-1 moa and se

A

increases synthesis of insulin in response to BG rise
no hypoglycemia, weight loss

17
Q

tzd moa and se

A

improves insulin sensitivity
NOT for HF, increased risk of fracture

18
Q

SGLT-2 inhibitor MOA and SE

A

prevents reabsorption of renal glucose
UTI, yeast infection

19
Q

pt with hx of heart failure- dm med rec?

A

sglt2

20
Q

initiation of basal insulin

A

start at 0.1-0.2 u/kg or 10 units
adjust by 2-4 units once-twice weekly to reach FBG goal

21
Q

most sensitive measure of thyroid disease

A

tsh
produced by anterior pituitary

22
Q

primary hypothyroidism labs

A

TSH: high
T4: low
T3: normal

23
Q

subclinical hypothyroidism labs:

A

TSH: high
T4: normal
T3: normal

24
Q

primary hyperthyroidism labs

A

TSH: low
T4: high
T3: normal/elevated

25
Q

most common cause of hypothyroidism

A

hashimoto’s thyroiditis

26
Q

subclinical hypothyroidism tx

A

treat if TSH>10

27
Q

levothyroxine replacement dose if young

A

1.6 mcg/kg/day

28
Q

levothyroxine replacement dose if middle age

A

50 mcg

29
Q

older adult levothryoxine replacement

A

25mcg

30
Q

recheck TSH how long after replacement starts

A

4-6 weeks

31
Q

metformin contra if

A

decreased GFR
elevated ALT, AST

32
Q

fasting blood glucose goal diabetes

A

80-130

33
Q

older adult fasting blood glucose goal

A

90-130

34
Q

postprandial glucose goal

A

<180